The main mechanisms of its anti-tumor effects are identified as: (i) a selective inhibition of cyclin-dependent kinase 4 (CDK4), which regulates the G0/S and G1/S checkpoint of the cell cycle. This evidence concerns the gene CDK4 and neoplasm.